• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子相关凋亡诱导配体在人膀胱癌细胞干扰素诱导凋亡中的作用

Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells.

作者信息

Papageorgiou Angela, Lashinger Laura, Millikan Randall, Grossman H Barton, Benedict William, Dinney Colin P N, McConkey David J

机构信息

Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

出版信息

Cancer Res. 2004 Dec 15;64(24):8973-9. doi: 10.1158/0008-5472.CAN-04-1909.

DOI:10.1158/0008-5472.CAN-04-1909
PMID:15604261
Abstract

Immunomodulators such as Bacillus Calmette-Guerin and interferon are clinically active in transitional cell carcinoma of the bladder, but their mechanisms of action remain unclear. Here we investigated the effects of IFNalpha on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and apoptosis in a panel of 20 human bladder cancer cell lines. Six (30%) displayed significant DNA fragmentation in response to increasing concentrations of IFNalpha (10-100,000 units/mL). In these lines IFNalpha induced early activation of caspase-8, and DNA fragmentation was blocked by a caspase-8-selective inhibitor (IETDfmk), consistent with the involvement of death receptor(s) in cell death. IFNalpha stimulated marked increases in TRAIL mRNA and protein in the majority of IFN-sensitive and IFN-resistant cell lines. A blocking anti-TRAIL antibody significantly inhibited IFN-induced DNA fragmentation in four of six IFN-sensitive cell lines, confirming that TRAIL played a direct role in cell death. Bortezomib (PS-341, Velcade), a potent TRAIL-sensitizing agent, increased sensitivity to IFNalpha in two of the IFN-resistant cell lines that produced large amounts of TRAIL in response to IFN treatment. Our data show that IFN-induced apoptosis in bladder cancer cells frequently involves autocrine TRAIL production. Combination therapy strategies aimed at overcoming TRAIL resistance may be very effective in restoring IFN sensitivity in a subset of human bladder tumors.

摘要

诸如卡介苗和干扰素之类的免疫调节剂在膀胱移行细胞癌中具有临床活性,但其作用机制仍不清楚。在此,我们研究了α干扰素对20种人膀胱癌细胞系中肿瘤坏死因子相关凋亡诱导配体(TRAIL)表达及凋亡的影响。六种(30%)细胞系在α干扰素浓度增加(10 - 100,000单位/毫升)时出现显著的DNA片段化。在这些细胞系中,α干扰素诱导半胱天冬酶-8的早期激活,并且DNA片段化被半胱天冬酶-8选择性抑制剂(IETDfmk)阻断,这与死亡受体参与细胞死亡一致。α干扰素在大多数对干扰素敏感和耐药的细胞系中刺激TRAIL mRNA和蛋白显著增加。一种阻断性抗TRAIL抗体在六种对干扰素敏感的细胞系中的四种中显著抑制了干扰素诱导的DNA片段化,证实TRAIL在细胞死亡中起直接作用。硼替佐米(PS - 341,万珂),一种有效的TRAIL增敏剂,在两种对干扰素耐药的细胞系中增加了对α干扰素的敏感性,这两种细胞系在接受干扰素治疗时产生大量TRAIL。我们的数据表明,干扰素诱导的膀胱癌细胞凋亡经常涉及自分泌TRAIL的产生。旨在克服TRAIL耐药性的联合治疗策略可能在恢复一部分人膀胱肿瘤对干扰素的敏感性方面非常有效。

相似文献

1
Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells.肿瘤坏死因子相关凋亡诱导配体在人膀胱癌细胞干扰素诱导凋亡中的作用
Cancer Res. 2004 Dec 15;64(24):8973-9. doi: 10.1158/0008-5472.CAN-04-1909.
2
Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.硼替佐米通过一种依赖p21的机制消除人膀胱和前列腺癌细胞中肿瘤坏死因子相关凋亡诱导配体的抗性。
Cancer Res. 2005 Jun 1;65(11):4902-8. doi: 10.1158/0008-5472.CAN-04-3701.
3
Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.使用细胞生长抑制剂与γ干扰素和肿瘤坏死因子相关凋亡诱导配体联合用药对神经母细胞瘤细胞凋亡的协同诱导作用
Int J Oncol. 2004 Dec;25(6):1849-57.
4
Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.通过长时间暴露于肿瘤坏死因子相关凋亡诱导配体而选择出的对凋亡具有抗性的人黑色素瘤细胞,对顺铂诱导的坏死性细胞死亡更敏感。
Clin Cancer Res. 2006 Feb 15;12(4):1355-64. doi: 10.1158/1078-0432.CCR-05-2084.
5
Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.干扰素γ诱导胱天蛋白酶8可使一些神经母细胞瘤(NB)细胞对肿瘤坏死因子相关凋亡诱导配体(TRAIL)敏感,但也表明缺乏膜TR1/TR2也导致NB对TRAIL耐药。
Cancer Res. 2003 Mar 1;63(5):1122-9.
6
Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells.组蛋白去乙酰化酶抑制剂可调节对肿瘤坏死因子相关凋亡诱导配体耐药的膀胱肿瘤细胞的敏感性。
Cancer Res. 2006 Jan 1;66(1):499-507. doi: 10.1158/0008-5472.CAN-05-3017.
7
Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.干扰素β在人癌细胞中通过Stat1依赖性诱导肿瘤坏死因子相关凋亡诱导配体及细胞表面死亡信号通路。
Cancer Res. 2003 Sep 1;63(17):5299-307.
8
Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.肿瘤坏死因子相关凋亡诱导配体在人卵巢癌细胞中对凋亡的差异性诱导作用
Gynecol Oncol. 2004 Jun;93(3):594-604. doi: 10.1016/j.ygyno.2004.03.029.
9
Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.肿瘤坏死因子相关凋亡诱导配体(TRAIL)触发的信号事件:TRAIL诱导的凋亡需要半胱天冬酶-8。
Cancer Res. 2001 Feb 1;61(3):1138-43.
10
Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.与干扰素(IFN)-α2相比,干扰素(IFN)-β对黑色素瘤细胞系凋亡的优先诱导作用:与TRAIL/Apo2L诱导的相关性
Clin Cancer Res. 2001 Jun;7(6):1821-31.

引用本文的文献

1
Review of BCG immunotherapy for bladder cancer.卡介苗免疫疗法治疗膀胱癌的综述。
Clin Microbiol Rev. 2025 Mar 13;38(1):e0019423. doi: 10.1128/cmr.00194-23. Epub 2025 Feb 11.
2
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model.单细胞 RNA 测序分析鉴定了干扰素 α 基因治疗在小鼠膀胱癌模型中诱导的肿瘤微环境的急性变化。
Front Immunol. 2024 Nov 4;15:1387229. doi: 10.3389/fimmu.2024.1387229. eCollection 2024.
3
Clinical use of nadofaragene firadenovec-vncg.
纳多法基因菲拉地诺韦克 - vncg的临床应用。
Ther Adv Urol. 2024 Sep 17;16:17562872241280005. doi: 10.1177/17562872241280005. eCollection 2024 Jan-Dec.
4
Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette-Guérin Immunotherapy of Bladder Cancer.突破壁垒:调节肿瘤微环境以增强卡介苗免疫疗法治疗膀胱癌。
Cells. 2024 Apr 18;13(8):699. doi: 10.3390/cells13080699.
5
Mechanism of action of nadofaragene firadenovec-vncg.纳多法基因菲拉地诺韦克 - vncg的作用机制。
Front Oncol. 2024 Mar 15;14:1359725. doi: 10.3389/fonc.2024.1359725. eCollection 2024.
6
Similar immune responses to alpha1-oleate and Bacillus Calmette-Guérin treatment in patients with bladder cancer.在膀胱癌患者中,α1-油酸和卡介苗治疗引起的免疫反应相似。
Cancer Med. 2024 Apr;13(7):e7091. doi: 10.1002/cam4.7091.
7
Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis.增强子簇驱动癌症中I型干扰素诱导的TRAIL过表达,且其细胞内蛋白质积累未能诱导细胞凋亡。
Cancers (Basel). 2023 Feb 3;15(3):967. doi: 10.3390/cancers15030967.
8
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance.膀胱癌细胞中I型干扰素诱导的细胞毒性的分子特征揭示了耐药生物标志物。
Mol Ther Oncolytics. 2021 Nov 12;23:547-559. doi: 10.1016/j.omto.2021.11.006. eCollection 2021 Dec 17.
9
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs.C-X-C基序趋化因子配体1维持乳腺癌干细胞自我更新并促进肿瘤进展和免疫逃逸程序。
Front Cell Dev Biol. 2021 Jun 14;9:689286. doi: 10.3389/fcell.2021.689286. eCollection 2021.
10
Role of tumor microenvironment in the efficacy of BCG therapy.肿瘤微环境在卡介苗治疗疗效中的作用。
Trends Res. 2020 Oct;3(4). doi: 10.15761/tr.1000170. Epub 2020 Aug 17.